• PVT1–HIF-1α Feedback in Pancreatic Cancer

  2026-08-20

  The 2021 reference study identifies a reciprocal regulatory loop in which the lncRNA PVT1 enhances HIF-1α transcription and protein regulation in pancreatic cancer. Its integrated expression, promoter, RNA–protein interaction, and functional assays provide a mechanistic framework for understanding how hypoxia-associated signaling may sustain tumor progression.

• Q-VD(OMe)-OPh in Multimodal Cell Death Studies

  2026-08-19

  Q-VD(OMe)-OPh is a broad-spectrum caspase inhibitor for dissecting apoptosis alongside ferroptosis and autophagy. This guide translates findings from cetuximab-resistant colorectal cancer research into practical assay and interpretation strategies.

• HO-1 and ROS Modulation in HBV Replication

  2026-08-19

  The reference study shows that isochlorogenic acid A suppresses HBV at multiple stages, linking HO-1 upregulation and intracellular ROS modulation to reduced viral gene expression, cccDNA, and defective particle morphogenesis. Its multi-readout design provides a useful framework for distinguishing effects on replication, capsid assembly, and envelopment while identifying limitations for translation beyond cell-based models.

• Epigenetic Silencing in Integrated Genetic Circuits

  2026-08-18

  The reference study shows that heterogeneous expression from CRISPR-Cas9-integrated multi-transcript circuits is driven primarily by local chromatin accessibility and epigenetic silencing rather than detectable sequence alteration. Its combination of fluorescent phenotyping, methylation and histone deacetylation perturbation, and ATAC-seq provides a practical framework for evaluating circuit stability in mammalian cells.

• Cy5-UTP for Fluorescent RNA Probe Synthesis

  2026-08-18

  Cy5-UTP enables direct, far-red visualization of RNA generated by T7 in vitro transcription, supporting FISH, expression-array workflows, and RNA delivery QC. This practical guide covers labeling design, assay controls, optimization, and the limitations of transferring fluorescent-tracer strategies into mRNA nanoparticle studies.

• AZD6482: PI3Kβ Precision for Translational Research

  2026-08-17

  AZD6482 is a selective, ATP-competitive PI3Kβ inhibitor that connects isoform-resolved kinase biology with platelet, metabolic, and hypothesis-driven disease-modeling workflows. This article examines its mechanistic value, experimental validation strategy, translational positioning, and cautious application to differentiation-dependent RNA-foci research in myotonic dystrophy type 1.

• 2-NBDG Glucose Uptake Assay Kit in HCC

  2026-08-17

  Learn how the 2-NBDG Glucose Uptake Assay Kit can separate glucose transport phenotypes from lipid-driven ferroptosis resistance in hepatocellular carcinoma. This evidence-based guide connects single-cell fluorescence with rigorous metabolic interpretation.

• Biotin-16-UTP: From RNA Labeling to Translation

  2026-08-16

  A mechanistic and strategic guide to using Biotin-16-UTP for in vitro RNA labeling, RNA-protein interaction studies, and translational investigation of lncRNA biology, with RNASEH1-AS1 in hepatocellular carcinoma as a model for moving from computational association to experimentally testable mechanism.

• XXLP in Ulcerative Colitis: NOX2–ROS–NLRP3

  2026-08-15

  This 2026 study integrates chemical profiling, proteomics, cell validation, and gut microbiota sequencing to investigate how Xu Chunfu’s Modified Xianglian Pill (XXLP) alleviates experimental ulcerative colitis. Its findings implicate coordinated suppression of the NOX2/ROS/mitochondria/NLRP3 axis alongside microbiota remodeling, while also highlighting the limits of translating chemically induced colitis results to human disease.

• Exemestane Workflow for Aromatase Research

  2026-08-14

  Build reproducible aromatase assays with Exemestane by combining enzyme-level estrogen measurements, exposure–response modeling, and washout tests for irreversible activity. Practical solvent controls, concentration guidance, and biomarker-aware comparisons help extend the compound from breast cancer research into robust hormone-biology workflows.

• SM-102 for Local mRNA Delivery: From LNP to Assay

  2026-08-14

  SM-102 can support mRNA delivery in lipid nanoparticles, but its value depends on formulation context and endpoint selection. This article translates recent p21 mRNA-LNP bladder cancer findings into a practical framework for evaluating local delivery, endosomal escape, and translational relevance.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer

  2026-08-13

  The reference study develops a localized, nonviral tumor-suppressor replacement strategy in which chemically modified p21 mRNA is packaged in lipid nanoparticles and delivered intravesically. Its data connect restored nuclear p21 expression with cell-cycle inhibition, DNA-damage signaling, apoptosis, and tumor suppression in an orthotopic bladder cancer model, while also highlighting the translational value of bladder-localized mRNA delivery.

• Lipo3K Transfection Reagent for Nucleic Acid Assays

  2026-08-13

  Lipo3K Transfection Reagent combines efficient nucleic acid delivery with a low-toxicity workflow suited to difficult cell models, plasmid expression, siRNA silencing, and co-transfection. This practical guide connects reagent selection and optimization with a 2026 study of pH-responsive antisense oligonucleotide prodrugs in MYCN-amplified cells.

• From P2RX1 Mechanism to Better Apoptosis Assays

  2026-08-12

  A translational perspective on how P2RX1-driven calcium and mitochondrial stress in Ph+ ALL can guide more informative apoptosis and necrosis measurements with the Annexin V-Cy5/DAPI Apoptosis Kit.

• A-1331852: BCL-XL Inhibitor Workflow Guide

  2026-08-12

  A-1331852 is a potent, selective BCL-XL inhibitor for dissecting mitochondrial apoptosis, resistance, and apoptotic priming. This practical guide connects concentration planning, mechanistic readouts, glioblastoma applications, combination sequencing, and troubleshooting.

16171 records 1/1079 page Next 12345 下5页 Last page